Centers | ||
Edinburgh Drug Discovery | Therapeutic Accelerator Program (TAP) | Collaborative Drug Discovery, Inc. |
Based within the world-leading University of Edinburgh Medical School, Edinburgh Drug Discovery has a track record in successfully translating drug discovery projects from target identification through to clinical evaluation. Key areas of... |
Test |
Chemical registration system Activity & Registration - Web application within CDD Vault for chemical registration, assay data management, and SAR analysis. |
Partnerships |
Events |
Jobs |
Bayer and UCSF Enter into a 10year Research & Development PartnershipBayer and University of California, San Francisco (UCSF) have signed a 10year master research and development agreement. The agreement provides a broad template for collaboration between the two groups around common areas of research interest... View all Sanofi and UCSF Establish Two Research Collaboration ProgramsSanofi has established two collaboration programs with University of California, San Francisco (UCSF). One collaboration pertains exclusively to oncology while the second one covers multiple therapeutic areas including oncology, inflammation,... View all Research Collaboration and license agreementThe Drug Discovery Unit announces a partnership with Takeda, Japan’s largest pharmaceutical company, to develop possible new therapeutic treatments for tau pathology, an underlying feature in several forms of neurodegeneration, including... View all |
No EVENTS for listing |
No Job Posts |


